An interventional study of Whole-Body Vibration Training and Aerobic Exercise Training in Primary Dysmenorrhea, sponsored by Gaziantep Islam Science and Technology University. Not yet recruiting. Open to female participants aged 18 Years to 28 Years. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Gaziantep Islam Science and Technology University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this clinical trial is to learn how whole-body vibration training and aerobic exercise training affect menstrual pain, symptom severity, and quality of life in young adult women with primary dysmenorrhea. Primary dysmenorrhea is menstrual pain that occurs without an underlying medical condition. It can interfere with daily activities and quality of life. Exercise may help manage menstrual pain, but more information is needed about the effects of different exercise approaches.
This study will examine the effects of whole-body vibration training and aerobic exercise training in young adult women with primary dysmenorrhea. Researchers will assess menstrual pain, the severity of menstrual symptoms, and quality of life. The findings may help inform exercise-based approaches to managing primary dysmenorrhea.
A total of 66 female student volunteers aged 18-29 years with primary dysmenorrhea who meet the eligibility criteria will be enrolled. Participants will be assigned to one of two groups: the Whole-Body Vibration Training Group (WBV) or the Aerobic Exercise Training Group (AE).
Both exercise programs will last eight weeks and will be conducted three days per week, for a total of 24 sessions. Participants in the WBV group will receive whole-body vibration training, while participants in the AE group will receive aerobic exercise training.
432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.
This study's planned enrollment of 66 is close to the median of 62 across 364 interventional studies indexed under Dysmenorrhea.
Browse Dysmenorrhea studies →Gaziantep Islam Science and Technology University is the lead sponsor of 43 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This programs will last 8 weeks, with exercise sessions 3 days per week.
Other: Whole-Body Vibration Training
This programs will last 8 weeks, with exercise sessions 3 days per week.
Other: Aerobic Exercise Training
Participants in this group will receive whole-body vibration training three days per week for eight weeks, for a total of 24 sessions. The vibration frequency will be set at 14 Hz and the amplitude at 8 mm. Each session will last approximately 45 minutes.
Participants in this group will receive aerobic exercise training three days per week for eight weeks. Each 45-minute session will consist of a 10-minute warm-up, 30 minutes of aerobic exercise, and 5 minutes of cool-down and stretching exercises.
Visual Analog Scale
Pain intensity will be assessed using a 10-cm Visual Analog Scale. Participants will mark the point on the line that best represents the intensity of their menstrual pain. The left endpoint represents "no pain," and the right endpoint represents "the worst pain imaginable." The distance from the left endpoint to the mark will be measured in centimeters, yielding a score from 0 to 10. Higher scores indicate more severe pain.
Time frame: Change from Baseline at 8 weeks
Menstrual Symptom Questionnaire
The Menstrual Symptom Questionnaire will be used to assess menstrual pain and symptom severity. It is a 24-item scale with five response options for each item. Participants will rate how often they experience each menstruation-related symptom, from 1 ("never") to 5 ("always"). The score is calculated as the mean of the 24 item scores and ranges from 1 to 5. Higher mean scores indicate more severe menstrual symptoms.
Time frame: Change from Baseline at 8 weeks
12-Item Short-Form Health Survey
The 12-Item Short Form Health Survey (SF-12) will be used to assess health-related quality of life. The Mental Component Summary score will be calculated according to the scoring method specified in the study protocol. The SF-12 contains 12 questions covering eight domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, bodily pain, social functioning, mental health, vitality, and general health. Each domain score ranges from 0 to 100. Higher scores indicate better mental health.
Time frame: Change from Baseline at 8 weeks
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Feb 2027, 4 months later.
Of 179 non-industry interventional studies with no phase under Dysmenorrhea, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's planned 4 months is below that.
Counting every sponsor, half of 189 studies reached it within 8 months; a quarter within 3 and three quarters within 17.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gaziantep Islam Science and Technology University